Login / Signup

A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS.

Leoni RolfesSteffen PfeufferTobias RuckSusanne WindhagenIlske OschliesHermann-Joseph PavenstädtLinus AngenendtHeinz WiendlJulia KrämerSven G Meuth
Published in: Neurology(R) neuroimmunology & neuroinflammation (2019)
Keyphrases
  • mass spectrometry
  • multiple sclerosis
  • case report
  • ms ms
  • newly diagnosed